Falcon Energy Materials PLC Closes C$25 Million Private Placement To Accelerate Project Development And Welcomes Significant New Shareholders

Executive Summary

• Falcon Energy Materials plc closed a non‑brokered private placement of 41,666,666 units at C$0.60 per unit, raising gross proceeds of C$25 million.
• Each unit consists of one ordinary share and one warrant to purchase an additional share at C$0.75 for 36 months; no commissions were paid.
• Proceeds will be used to advance Falcon’s strategic graphite projects in Morocco and for general working capital, subject to a four‑month statutory hold period and final TSX Venture Exchange approval.

Key Details

• Units sold: 41,666,666 units (each = 1 ordinary share + 1 warrant).
• Price per unit: C$0.60 → Gross proceeds: C$25 million.
• Warrant terms: Right to purchase one additional share at C$0.75 per share, exercisable for 36 months from closing.
• Key investors: Argentem Creek Partners (USA) and several high‑profile investors from the Middle East and Europe; La Mancha Resource Fund exercised anti‑dilution rights.
• Largest shareholder post‑closing: La Mancha Investments S.à.r.l. holds 24.1% of fully diluted shares.
• Use of proceeds: Development of strategic projects in Morocco (including a 25 ktpa CSPG production facility) and general working capital.
• Hold period: All securities subject to a statutory four‑month hold until June 21 2026 under Canadian securities law.
• Commissions: None paid in connection with the placement.
• Regulatory status: Units, shares, warrants, and warrant shares not registered under U.S. securities laws; offering limited to jurisdictions where lawful.
• Related‑party transaction: Insiders (including La Mancha) received units; exemption relied upon as consideration does not exceed 25% of market cap.
• Pending approval: Private placement remains subject to final TSX Venture Exchange approval.

Notable Quotes

“We are extremely pleased with the strong investor confidence demonstrated by the successful closing of this Private Placement,” said Matthieu Bos, President & CEO.

All boilerplate, forward‑looking statements, and disclaimer text have been omitted for brevity.